Novartis, Panacea call off JV; Norway's Algeta beats forecasts;

@FiercePharma: China arrests British consultant and wife for trafficking in private information. Pharma probe churns on… Yesterday's story | Follow @FiercePharma

@EricPFierce: Swiss CMO Siegfried building a manufacturing plant in China. ICYMI from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: Eye-drug specialist Akorn buys rival Hi-Tech for $640M. Article | Follow @CarlyHFierce

> Chiron, Novartis' ($NVS) vaccines unit, and Delhi-based Panacea have called off their joint venture for pediatric vaccines. Story

> Norway's Algeta bested Q2 earnings forecasts and said it has received a milestone payment for Xofigo, the prostate-cancer drug it markets with Bayer. Report

> Germany's PHW Group is considering a sale of its animal health unit. Story

> Eli Lilly ($LLY) has elected Dr. Marschall Runge, currently the executive dean for the School of Medicine at the University of North Carolina at Chapel Hill, to its board. Report

> Merck KGaA is donating 6 million praziquantel tablets to Sudan for large-scale treatment of schistosomiasis. Article

Medical Device News

@FierceMedDev: Sign up to receive our new publication FierceDiagnostics in your inbox each Wednesday. Sign up here | Follow @FierceMedDev

@DamianFierce: J&J is switching up its Chinese leadership as local authorities eye drug and device firms. News | Follow @DamianFierce

@MarkHFierce: The sleep apnea device industry is poised to get an infusion of a number of new treatments. ICYMI yesterday | Follow @MarkHFierce

> GlySure glucose monitor tests well in hospital trial. Item

> Study: Insulin pump beats injection in kids with Type 1 diabetes. Article

> InVivo tanks after pushing back spinal study. More

Biotech News

@FierceBiotech: ICYMI from FierceCRO: PPD snags Acurian for recruitment software. News | Follow @FierceBiotech

@JohnCFierce: No Teva deal for Rexahn. Press release | Follow @JohnCFierce

@EmilyMFierce: This week's issue of FierceBiotech Research. Not subscribed? Sign up for free here. | Follow @EmilyMFierce

> Onyx spells out layoff policies as staffers brace for post-buyout cuts. More

> Cramer vs. Cramer: What's the next big biotech takeover target? News

> Gilead's sofosbuvir cures some of the toughest hepatitis C cases. Article

Drug Delivery News

@MichaelGFierce: Ceptaris nets first-ever FDA approval for topical lymphoma chemo gel. Article | Follow @MichaelGFierce

> Chip lined with human cells tests cancer drug delivery with minimal cost. Story

> Singapore team makes 'nanocages' for protein drug delivery. Article

> Lipidor, Karolinska post sound PhI/IIa results for novel spray-on psoriasis drug. News

> Nano-gold's penetrating methods revealed in MIT, Swedish study. More

> FDA clears Novo Nordisk's insulin injection pen for children. Item

Diagnostics News

> U Texas group finds ovarian cancer Dx works better over time. More

> Harvard, Danish team develop new brain cancer MRI approach. Story

> Applied Proteomics mulls Alzheimer's companion Dx. Article

> Life Technologies loses exec to Dx startup. Item

> Exosome, Mount Sinai forge Dx development partnership. Report

And Finally... Would a mirror in your shopping cart inspire you to buy more produce? How about neon arrows to the fruits and vegetables aisle? Two social scientists in El Paso are using new tactics to get Americans to change their eating habits. Story

Suggested Articles

Transporting pharmaceutical products at <-60C for more than 96 hours has seemed an insurmountable challenge. TOWER’s solution has solved the problem.

The countdown to the FDA's first coronavirus vaccine hearing has begun, and new agency documents outline an agenda for the Thursday confab.

Black Americans’ confidence in COVID-19 vaccines is dropping, with only 43% saying they will get a vaccine once it's out—down 22 points since August.